Different power of AUC vs. Cmax at stage I - continuation rules [Two-Stage / GS Designs]

posted by Nisha – Israel, 2015-09-17 15:28 (3438 d 14:38 ago) – Posting: # 15419
Views: 7,248

Hi all,
I would like to raise a scenario following stage I results with Potvin C:

If, hypothetically, our results at stage I would have had good ratio, and failed to meet 94.12% CI BE criteria at stage I for both Cmax and AUC.
The power analysis would have shown results higher than 80% for AUC, and lower than 80% for Cmax. Based on Cmax, we could continue to stage II. In that case - what would be the practice for AUC? I would assume it would have been calculated also for stage II. How should this be covered in the protocol?

Would appreciate your input.

Many thanks,
Nisha

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,665 registered users;
75 visitors (0 registered, 75 guests [including 13 identified bots]).
Forum time: 05:07 CET (Europe/Vienna)

When people learn no tools of judgment
and merely follow their hopes,
the seeds of political manipulation are sown.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5